We next assessed whether FLT3-overexpressing cells are chemoresistant in human ETP-ALL, by measuring the numbers of KF cells at 24 h after VXL chemotherapy in mice engrafted with PDX ETP-5 (Fig. 4G). The gene discussed is FLT3; the disease is acute lymphoblastic leukemia.